Mothers’ Diabetes Linked to ADHD in Their Children

Children born to women who develop diabetes either before or during their pregnancy could be at risk for developing attention-deficit/hyperactivity disorder, data from a large multinational cohort study appear to show. Considering more than 4.5 million mother-child pairs, it was found that children whose mothers had diabetes around the time of their pregnancy were 16% … Read more

Brain Shrinkage in First-Time Dads: It’s a Good Thing

First-time fathers appear to experience a loss of cortical volume following the birth of their child, new research suggests. Investigators associated with the Instituto de Investigación Sanitaria Gregorio Marañón in Madrid, Spain, and the University of Southern California compared MRIs of the brains of 40 new fathers (half located in the United States and the … Read more

Is Corporate Telepsychiatry the Solution to Access to Care Problems?

When Sue W’s mother died in 2018, she struggled terribly. She was already seeing a psychotherapist and was taking duloxetine, prescribed by her primary care physician. But her grief was profound, and her depression became paralyzing. She needed to see a psychiatrist, and there were many available in or near her hometown, a Connecticut suburb … Read more

WPATH Removes Age Limits From Transgender Treatment Guidelines

Long-awaited global transgender care guidelines have dropped, with no recommendations regarding age limits for treatment and surgery in teenagers but acknowledging the complexity of dealing with such adolescents amid lack of longitudinal research on the impact of transitioning gender. The World Professional Association of Transgender Health (WPATH) published its latest standards of care (SOC) 8 … Read more

Ketamine Promising for Rare Condition Linked to Autism

Ketamine may be an effective treatment for children with activity-dependent neuroprotective protein (ADNP) syndrome, a rare genetic condition associated with intellectual disability and autism spectrum disorder. Also known as Helsmoortel–Van Der Aa syndrome, ADNP syndrome is caused by mutations in the ADNP gene. Studies in animal models suggest that low-dose ketamine increases expression of ADNP … Read more

Clozapine Best Choice for Reducing SUD Risk in Schizophrenia?

Clozapine or antipsychotic polytherapy appear to be the best approach in reducing the risk for a substance use disorder (SUD) in adults with schizophrenia and for preventing relapse in patients with both diagnoses, results of a real-world study show. “Our findings are in line with a recent meta-analysis showing superior efficacy of clozapine in schizophrenia … Read more

Telehealth Benefits for OUD Prompts Call for Permanent Adoption

A new study provides strong support for permanent adoption of expanded telehealth services and flexible prescribing of medications for opioid use disorder (OUD), experts say. Results showed that expanded access to telehealth services, authorized during the COVID-19 pandemic, led to more Medicare beneficiaries with OUD entering treatment and staying in treatment, as well as to … Read more

Home-Based Stimulation Linked to ‘Clear Improvement’ in Adult ADHD

Transcranial direct current stimulation (tDCS) using a home-based device can help improve attention in adults with attention-deficit/hyperactivity disorder (ADHD) who are not taking stimulants, new research suggests. Results from the sham-controlled trial also showed that the tDCS treatment was both safe and well tolerated. Overall, the findings suggest that the device could be a nondrug … Read more

Stable, Long-term Opioid Therapy Safer Than Tapering?

Discontinuing Stable, Long-TERM OPIOIID Therapy May Not BE NECESAY FOR PATIENTS who show no Signs of Misuse ― and IT COUL Even Be Safer Than Tapering Or Aburt Discontinism, New Research Suggests. Investigators Analyzed Data for Almost 200,000 Patients who did not have signs of OPIOOID USE DISEORDER (Oud) and Were Receiving Opioid Treatment. The … Read more

What Ketamine and Psilocybin Can and Cannot Do in Depression

Recent studies with hallucinogens have raised hopes for an effective drug-based therapy to treat chronic depression. At the German Congress of Psychosomatic Medicine and Psychotherapy, Torsten Passie, MD, PhD, professor of psychiatry and psychotherapy at the Hannover Medical School, gave a presentation on the current state of psilocybin and ketamine/esketamine research. Passie, who also is … Read more